Xap Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Xap Therapeutics?

Xap Therapeutics is funded by Amplitude Venture Capital.

Q: When was the last funding round for Xap Therapeutics?

Xap Therapeutics closed its last funding round on obfuscated from a Venture - Series Unknown round.

Overview

Xap Therapeutics

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Xap Therapeutics

CB Rank

442466

Xap Therapeutics develops synthetic biology-driven platform designed for cell therapeutics.

Founded

obfuscation

Private

Venture - Series Unknown

Cambridge, Cambridgeshire, United Kingdom

1-10

www.xaptherapeutics.com/

Biotechnology

Health Care

Health Diagnostics

Medical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Key People

Shaun Foy: Founder and Executive Director
Past Role: SR One, Venture Partner

Details

Legal Name

Xap Therapeutics Ltd

Operating Status

Active

Company Type

For Profit

Founders

James Patterson, Shaun Foy

About the Company

Xap Therapeutics is a start-up biotechnology company that is developing an innovative, synthetic biology-driven platform for cell therapeutics.

Xap Therapeutics, formed by biotech entrepreneurs, is a producer of a "chassis" cell which functions in cell therapies through genetically engineered constructs.

Xap Therapeutics was

established in 2017 by James Patterson, M.D., Ph.D in Cambridge, England.

Predictions & Insights

Growth Insight

See this Growth Insight

Xap Therapeutics is

Lorem

to be growing

Top Contributing Factors

Operations Expansion

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

Synthetic Biology-Driven Platform

A platform that uses genome editing and synthetic biology to create modular cells programmed to treat diseases by delivering therapeutic payloads such as cytokines, antibodies, and nucleic acids.

Multi-Modal Therapies

Therapies designed to treat complex diseases, including cancer and autoimmune disorders, by using a variety of therapeutic approaches.

Research & Development

Xap Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Xap Therapeutics	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Xap Therapeutics	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Xap Therapeutics	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Xap Therapeutics	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Xap Therapeutics	1	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Xap Therapeutics	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Xap Therapeutics	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Xap Therapeutics	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Xap Therapeutics	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Xap Therapeutics	1	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Amplitude Venture Capital	—	Venture Round - Xap Therapeutics	—
Amplitude Venture Capital	—	Venture Round - Xap Therapeutics	—
Amplitude Venture Capital	—	Venture Round - Xap Therapeutics	—
Amplitude Venture Capital	—	Venture Round - Xap Therapeutics	—
Amplitude Venture Capital	—	Venture Round - Xap Therapeutics	—